Member Info for MarkBellUK

The trend is not always your friend

GOLDMAN SACHS CUTS MICRO FOCUS PRICE TARGET TO 600 (630) PENCE - 'BUY'

Well this is now the 9th (yes ninth!) monday in a row when it has been down only to recover the rest of the week (on most weeks)..very predictable

But CS also forecast a 10% increase in share price

"Glaxo Smith Kline gets a second shot at vaccine glory
The pharma giant hopes to develop jabs for new Covid variants"

This could well surprise a few people next week (myself included) and even ex dividend

Barclays have it 8X FY22E /NoPat whilst Stifel:-

Forecast changes. We upgrade FY2021E revenue to US$2,812.0m, prior US
$2,791.1m with adj. EBITDA to US$1058.3m, prior US$1128.1m. We forecast a DPS of
US28.51cents, and generate FY2023 estimates for the first time. We note consensus
(source: Reuters) revenue of US$2,849m and adj. EBITDA of US$1,081m. See inside
for assumptions. Forecast changes and some ForEx bumps our target price to 1,402p
(prior 1,419p).

Median price target now 546 (12 Analysts)...Barclays being the lowest of all as they have their numbers wrong but will no doubt not bother to revisit and reissue even though they charge heavily for their notes

Median target is 1580 as of today (23 Analysts). AndItsGone hold if your mental state allows and I dont mean that in a derogatory sense. Its not worth making yourself ill, BUT if you do sell you are doing so to someone like me who will just sit through all the sh*t take the dividends and at least wait for the median

Thats this afternoon thanks Mr Dent

GlaxoSmithKline: Berenberg reiterates buy with a target price of 1,570p.

Whilst AJ Bell's shares mag, in todays issue, posted a positive article with a BUY citing "the attractions remain in place and investors should buy on current share price weakness"

Toli see 100notout post below!

I just think its very sad when a British institute (Barclays) cant be bother to spend the time and care to get the numbers even remotely right for another British company (same at GSK) when the Swiss and others can. Yet they are willing to issue a damaging note with no sign off / sanity check in place. Its embarrassing IMHO

* Micro focus : Credit Suisse raises target price to 540p from 350p

>Chinese New Year. Year of the Ox / Bull. It’ll be impossible to lose money this year. Chinese zodiac said so.

.........And back in the room

So to be clear you think its a delayed (36 hours?) considered view regarding write downs that happens coincidentally (within minutes) of the issuing of a flawed broker note from Barclays?

lol it is also clearly flawed ;)

wishful thinking

To be clear the chart clearly shows that on issuing the note the price collapsed circa 10% ( I dont believe that is even open for debate its that clear). On inspection of said note it is clearly floored

Make of that what you will

Matt you can work the numbers. Study the full Barclays note from todays, their "model update" then let me know what you think

They cant even be bother to update the yield!

https://ibb.co/GHctxnZ